UCLA neurosurgeons testing Oculus Rift to step inside patients’ brains
The technology enables surgeons to enter the virtual brain, examine the brain tumor or aneurysm, and plan the surgical strategy and operative steps.
Researchers at UCLA testing apps to fight addiction
As part of the first-ever clinical behavioral mHealth clinical trial at UCLA, the project involves providers prescribing a smartphone app to their patients.
Japan Post Group, IBM and Apple team-up to mobilize care for the elderly in...
The initiative will deliver iPads with IBM-developed apps and analytics to connect millions of seniors with services, healthcare, community and their families.
Interview with Harsh Vathsangam, CEO of Moving Analytics
The company helps hospitals increase enrollment in and revenues from cardiac rehab; it enables hospitals to implement home- and mobile-based programs.
China’s on-demand massage app raises $5M Series A
At the moment, Diandao only has massage therapists in Beijing and Shanghai, and will use the money to expand to other cities and grow its platform.
Apple ResearchKit apps will require ethics board review
Apps conducting health-related human subject research must secure approval from an independent ethics review board; proof must be provided upon request.
DentalPlans launches its first telehealth plan
With :DP HealthNow plan, patients get inexpensive access to some of the best modern healthcare in the form of expert advice and professional services.
Imprivata enters the patient identification market with acquisition of HT Systems
The acquisition helps Imprivata become the leading provider of health IT security solutions that enable patient engagement, and improve patient safety.
MultiCare Health System launches telehealth service powered by Doctor On Demand
The service provides patients with immediate access to a Board Certified physician for a wide range of medical issues; the cost of each Video Visit is $40.
Interview with Pear Therapeutics’ founder and CEO – Corey McCann MD, PhD
The company has offices in Boston and San Francisco, and is developing drug/software combination products to address a broad range of severe conditions.









